Loading clinical trials...
Loading clinical trials...
A Phase-IIa, Double-blind, Randomized, Placebo-controlled Study on the Safety and Early Efficacy of Alkaline Phosphatase in Sepsis Patients With Renal Failure
Conditions
Interventions
Placebo
BIAP
Locations
9
Belgium
University Medical Center Antwerp (UZA)
Antwerp, Belgium
Cliniques Universitaires Saint Luc-UCL
Brussels, Belgium
ULB Hopital Erasme
Brussels, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
UMC Nijmegen University Medical Center St Radboud
Nijmegen, Gelderland, Netherlands
Isala Clinics
Zwolle, Overijssel, Netherlands
Start Date
May 1, 2008
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
April 2, 2012
NCT04850456
NCT04955210
NCT07179276
NCT05267821
NCT07448805
NCT07351344
Lead Sponsor
AM-Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions